JH
Congress trade
Sen. John Hoeven (R-ND) bought $50K-$100K of Pfizer Inc. (PFE) stock
John Hoeven, U.S. Senator (R-ND), disclosed a purchase of Pfizer Inc. (PFE) stock worth $50K-$100K in a STOCK Act filing on Dec 7, 2016.
The trade happened on Nov 25, 2016, 12 days before it was made public.
PFE has moved -7.5% since the trade date, from $30.07 to $27.80 (Oct 2, 2026 close).
- Traded
- Nov 25, 2016
- Disclosed
- Dec 7, 2016
- Filing delay
- 12 days
- Price since
- -7.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.